Results 201 to 210 of about 53,577 (300)

Factors Associated With Perceived Cognitive Dysfunction in Patients With Primary Brain Tumors: The Utility of the Neuro-QoL Cognition Function Scale. [PDF]

Cancer Med
Johnson M, Reinhart K, Guedes VA, Wright ML, Vera E, Acquaye-Mallory A, Miller H, Choi A, Kunst T, Reyes J, Wu J, Penas-Prado M, Ozer B, Burton E, Gilbert MR, Armstrong TS, Mendoza T.   +16 more
europepmc   +1 more source

Bipolar Disorder and the Risk of Cardiovascular Diseases: A Systematic Review and Meta‐Analysis of Observational Studies

Acta Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Bipolar disorder (BD) is a chronic psychiatric illness characterized by recurrent manic and depressive episodes, affecting 2% of the global population. It is associated with premature mortality, including cardiovascular disease (CVD)‐related mortality.
Fernando Daibert de Souza Motta, Matheus de Lima Ruffini, Amanda Cunha Ritter, Sofia Moreira Ferrão, Rodrigo Sousa Silva, Nicole da Silva Mastella, Bruno Braga Montezano, Elias Ajub Neto, Flávio Kapczinski, Jairo Vinícius Pinto, Ives Cavalcante Passos   +10 more
wiley   +1 more source

Validated LC-MS/MS Assays for Novel Triazolyl-Oxazolidinones with Anticonvulsant Activities and Their Potential Applications in Stability and Pharmacokinetic Studies. [PDF]

Pharmaceuticals (Basel)
Hedaya MA, Phillips OA, Thomas V, Qaddoumi MG, Kombian SB, Al-Tannak NF.   +5 more
europepmc   +1 more source

Comparative effectiveness, safety and acceptability of pharmacological and psychosocial interventions for the treatment of cannabis use disorder: A network meta‐analysis

Addiction, EarlyView.
Abstract Aim Our primary aim was to conduct a network meta‐analysis (NMA) for the effectiveness, safety and acceptability of all psychosocial interventions and all pharmacotherapies for cannabis use disorder (CUD). Methods We conducted a NMA of studies identified from two completed systematic reviews examining the effectiveness, safety and ...
Monika Halicka, Francesca Spiga, Tom P. Freeman, Suzanne Nielsen, Jelena Savović, Julian P. T. Higgins, Deborah M. Caldwell   +6 more
wiley   +1 more source

Anticonvulsant drugs and growth kinetics of gut commensal Escherichia coli isolates from familial Mediterranean fever disease patients. [PDF]

Sci Rep
Sirakanyan S, Stepanyan L, Hakobyan E, Hovakimyan A, Pepoyan A, Balayan M.   +5 more
europepmc   +1 more source

Clobazam to preserve meaningful engagement in prolonged disorder of consciousness with concurrent seizure disorder

PM&R, EarlyView.
Tatiana Bernstein, Zachary Miklja, Tiffany Wood, Joshua Startup   +3 more
wiley   +1 more source

Beyond abstinence: Redefining success in cannabis use disorder treatment

Addiction, EarlyView.
Abstract Background Over two decades of pharmacotherapy research has yet to yield a consistently effective medication for cannabis use disorder (CUD), in part because clinical trials have frequently prioritized abstinence as a primary or key endpoint.
Tobias B. Atkin, Frances R. Levin, John Mariani, Christina A. Brezing   +3 more
wiley   +1 more source

Studies on the anticonvulsant potential of 6-gingerol, an active ingredient of ginger rhizome. [PDF]

Front Pharmacol
Nieoczym D, Kukula-Koch W, Szafarz M, Vuong J, Grenda A, Tarabasz D, Pierog M, Marszalek-Grabska M, Szulc M, Esguerra CV, White HS, Gawel K.   +11 more
europepmc   +1 more source

Accidental overdose admissions and premature death: A large population‐based data‐linkage cohort study in New South Wales, Australia (PAVLOVA 4)

Addiction, EarlyView.
Abstract Background and aims People with substance use disorders have reduced life‐expectancy; however, risks of premature death from injuries and natural causes following an accidental overdose are not well characterised. This study aimed to estimate risk of premature death (by cause and over time), and disease burden following hospitalised accidental
Firouzeh Noghrehchi, Rose Cairns, Darren M. Roberts, Kirsten C. Morley, Paul S. Haber, Nicholas A. Buckley   +5 more
wiley   +1 more source

Anticonvulsant effects, safety, and sex-dependent molecular signatures of cannabidiol treatment in a preclinical model of audiogenic epilepsy. [PDF]

Front Pharmacol
Cabral-Pereira G, López DE, Gómez-Nieto R.   +2 more
europepmc   +1 more source